During the past decade, Endocrinology Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Endocrinology Unit" #1 collaborator was "DOC generici srl" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Endocrinology Unit" are "Cognitive Deficit" (1 trials), "Dysglycemia" (1 trials) and "Dyslipidemias" (1 trials). Many other conditions were trialed in "Endocrinology Unit" in a lesser frequency.

Most popular intervention types in "Endocrinology Unit" are "Dietary Supplement" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Coleosoma" (1 trials), "Exenatide" (1 trials), "Placebo" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Endocrinology Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Endocrinology Unit". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Endocrinology Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Endocrinology Unit, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".